DEF 14C: Datavault AI Stock Issuance Approved for Nasdaq Compliance

Datavault AI Inc. announced that its majority stockholders approved the issuance of 5 million common shares to certain purchasers to comply with Nasdaq listing rules and in exchange for waivers on prior securities agreement terms.

Summary

• Majority stockholders of Datavault AI Inc. approved the issuance of 5,000,000 shares of Common Stock via written consent on August 27, 2025.
• This action was taken to comply with Nasdaq Listing Rule 5635(d), which requires stockholder approval for issuances exceeding 20% of outstanding shares at a price below the Minimum Price in certain non-public offerings.
• The shares are being issued to purchasers who were party to a March 31, 2025, securities purchase agreement, in consideration for their waiver of variable rate transaction provisions and participation rights for a 60-day period.
• In return for the waivers, the Company agreed to restrictions on future Common Stock sales through Maxim Group LLC for 60 days or until the purchasers no longer hold notes, including limits on trading volume (10%), price (not below $1.10), and aggregate amount (not exceeding $25,000,000).
• The actions will be implemented at least 20 days after the Information Statement is first mailed to stockholders on or about September 26, 2025.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, purely informational. The underlying action (issuing shares for waivers) has both positive (compliance, waiver of restrictive terms) and negative (dilution, potential influence) aspects, balancing out the immediate sentiment.

Positives

• Secured waivers from purchasers on potentially restrictive variable rate transaction provisions and participation rights for 60 days.
• Ensures compliance with Nasdaq Listing Rule 5635(d), maintaining the company's listing status.
• The waiver agreement includes restrictions on future stock sales, such as a minimum price of $1.10 per share and a maximum aggregate amount of $25,000,000, which could provide some stability.

Negatives

• The issuance of 5,000,000 shares of Common Stock will result in dilution of existing stockholders' percentage ownership.
• The issuance could result in the purchasers beneficially owning a significant amount of Common Stock, potentially allowing them to significantly influence future Company decisions.
• The shares are issued in consideration for waivers, indicating the company needed to offer equity to modify terms of a previous financing agreement.

Risks

• Significant dilution of existing stockholders' equity and voting power due to the issuance of 5,000,000 shares.
• Increased influence of the purchasers over company decisions if they acquire a significant beneficial ownership stake.
• Reliance on forward-looking statements, which are subject to various factors and may differ materially from actual results.

Future Outlook

The filing primarily details a past corporate action and does not provide specific forward-looking guidance on financial performance, new products, or services. It includes a standard disclaimer regarding forward-looking statements, noting that actual results may differ materially from expectations due to various risk factors.

Management Comments

• By Order of the Board of Directors, /s/ Nathaniel Bradley Nathaniel Bradley Director and Chief Executive Officer

Industry Context

This filing is a standard corporate governance disclosure related to financing activities and Nasdaq compliance. It does not provide specific operational or strategic details that would allow for a detailed analysis of broader industry trends or competitive positioning. The issuance of shares for waivers suggests ongoing financing management, a common activity for companies, particularly those seeking to optimize capital structure or manage existing debt/equity terms.

Comparison to Industry Standards

• The filing does not contain specific financial or operational results that can be directly compared to global benchmarks or specific comparable companies.
• The action of seeking stockholder approval for a significant share issuance (over 20% of outstanding shares) to comply with exchange listing rules (Nasdaq Rule 5635(d)) is a standard corporate governance practice for publicly traded companies.
• The use of waivers in exchange for equity is a common mechanism in financing, particularly when modifying terms of existing agreements, but the specific terms (e.g., $1.10 minimum price) would need context from the original March 2025 Purchase Agreement to assess their favorability relative to market conditions at the time.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Existing shareholders will experience dilution of their percentage ownership due to the issuance of 5,000,000 new shares.
• Purchasers: Will receive 5,000,000 shares of Common Stock and potentially gain significant influence over future Company decisions.

Next Steps

• The approved actions will not be implemented until at least 20 days after the Information Statement is first mailed to stockholders (on or about September 26, 2025).
• The Company will continue to file reports, proxy statements, and other information with the SEC, including annual and quarterly reports on Form 10-K and 10-Q.

Key Dates

Recommendation

The filing details a necessary corporate action to comply with Nasdaq rules and manage terms of previous financing. While the issuance of 5,000,000 shares will cause dilution and potentially increase the influence of certain purchasers, the waivers obtained could be beneficial in the short term. Without further financial or operational updates, a "hold" recommendation is appropriate, advising investors to monitor the impact of dilution and the company's future performance.

Keywords

Datavault AI, DVAI, SEC filing, DEF 14C, stock issuance, Nasdaq compliance, Rule 5635(d), stockholder approval, dilution, waiver agreement, securities purchase agreement, common stock, corporate governance